ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Rochester, MN, USA:

Niraparib + Dostarlimab in BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Enrolling
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Rochester, Minnesota, United States and 8 other locations

This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...

Active, not recruiting
Inflammatory Breast Cancer (IBC)
Drug: Paclitaxel
Drug: Cyclophosphamide

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Rochester, Minnesota, United States and 3 other locations

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Enrolling
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Rochester, Minnesota, United States and 9 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Rochester, Minnesota, United States and 9 other locations

This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and whi ...

Enrolling
Male Breast Cancer
Hormone Receptor-positive Breast Cancer
Drug: Tamoxifen
Drug: Anastrozole

Phase 2

Jose Pablo Leone

Rochester, Minnesota, United States and 4 other locations

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

Active, not recruiting
Metastatic Breast Cancer
FGFR 1 High Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Phase 2

Taiho Pharma
Taiho Pharma

Rochester, Minnesota, United States and 36 other locations

In this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer th...

Active, not recruiting
Breast Cancer
Drug: Lapatinib
Drug: Herceptin

Phase 2

Nancy Lin, MD

Rochester, Minnesota, United States and 8 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Rochester, Minnesota, United States and 117 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Rochester, Minnesota, United States and 32 other locations

Locations recently updated

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

Rochester, Minnesota, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems